JPRN-UMIN000026815已完成未知
Postoperative visceral tissue edema assessed by computed tomography is a predictor of severe complications after pancreatoduodenectomy - Postoperative visceral tissue edema assessed by computed tomography after pancreatoduodenectomy
Wakayama Medical University, School of Medicine0 个研究点目标入组 200 人开始时间: 2017年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
Severe complication (Clavien-Dindo more than grade III) rate was significantly higher in Liberal fluid management(LFM) group than Goal-directed fluid management(GDFT) group (37% vs. 17%, P = 0.001).
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with combined other organs 2) patients rejected to participate in this study
研究者
相似试验
Unknown
不适用
Intraoperative Hyperglycemia and Infections After Orthopedic SurgerySevere HyperglycemiaPostoperative InfectionOrthopedic PatientsNCT03903354Federico Bilotta1,000
已完成
3 期
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative IleusIleusNCT00205842Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)660
已完成
3 期
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative IleusIleusNCT00388258Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)451
已完成
3 期
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative IleusIleusNCT00388479Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)666
已完成
3 期
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative IleusIleusNCT00388401Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)510